Runners celebrate first-generation immigrants with a color run
The 3K Color Run was one of the last festivities of the annual Irvine Tech Week.
Source: ocregister.com
John Shen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Shen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Shen Today - Breaking & Trending Today
APEX-01 Looks to Add First PSMA-Directed ADC to Treatment Paradigm in mCRPC
John Shen, MD, discusses the phase 1/2 APEX-01 trial of ARX517 in metastatic castration-resistant prostate cancer.
Source: onclive.com
Dr Shen on the Tolerability and Efficacy of ARX517 in mCRPC
John Shen, MD, discusses unique features associated with the use of the prostate-specific membrane antigen–directed antibody-drug conjugate ARX517 in patients with metastatic castration-resistant prostate cancer and highlights early efficacy and safety findings with this agent.
Source: onclive.com
ARX517 Demonstrates Early Efficacy With Favorable Safety in Heavily Pretreated mCRPC
ARX517 displayed preliminary efficacy and a strong safety profile in patients with metastatic castration-resistant prostate cancer, according to findings from the phase 1/2 APEX-01 study.
Source: onclive.com
Ambrx Provides Safety and Efficacy Data from Ongoing Phase 1/2 APEX-01 Trial of ARX517 in mCRPC at ESMO Congress
Newly published abstract regarding dose escalation patients provides key updates including: ≥50% PSA reduction observed across putative therapeutic dose levels ≥2.0 mg/kg – 3 of 3 in Cohort 6...
Source: marketscreener.com